Share on StockTwits

Rockwell Medical (NASDAQ:RMTI) issued its quarterly earnings data on Thursday. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.05, Stock Ratings Network reports. The company had revenue of $13.00 million for the quarter, compared to the consensus estimate of $13.45 million. The company’s revenue for the quarter was up .2% on a year-over-year basis.

On the ratings front, analysts at TheStreet downgraded shares of Rockwell Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, May 14th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $14.10.

Rockwell Medical (NASDAQ:RMTI) traded down 3.16% on Thursday, hitting $10.10. The stock had a trading volume of 245,469 shares. Rockwell Medical has a one year low of $4.85 and a one year high of $15.85. The stock has a 50-day moving average of $11.1 and a 200-day moving average of $11.35. The company’s market cap is $411.7 million.

Rockwell Medical, Inc, formerly Rockwell Medical Technologies, Inc, manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.